ATORVASTATIN MSN
40MG TBL FLM 100
| SÚKL code | 0262963 |
|---|---|
| Name of the product | ATORVASTATIN MSN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ATORVASTATIN MSN |
| Supplement | 40MG TBL FLM 100 |
| Strenght | 40MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 100 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | ATORVASTATIN CALCIUM TRIHYDRATE (ATORVASTATINUM CALCICUM TRIHYDRICUM) |
| ATC group | C10AA05 |
| ATC group name | ATORVASTATIN |
Marketing authorisation information
| Registration Number | 31/ 318/18-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 09. 2022 |
| MA Holder | MEDREG s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | MEDREG s.r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz